Bernstein Maintains Underperform on Rivian, $6.10 Price Target

Apr 14, 2025 Analyst: Daniel Roeska 1 min read Reproduced verbatim
Rating
Sell
Price target
$6.10
Implied downside
-47%
vs $11.47 prior close
Bernstein and Rivian logos

Bernstein SocGen Group analyst Daniel Roeska reiterated an Underperform rating and $6.10 price target on Rivian Automotive Inc (NASDAQ: RIVN).

“We continue to value Rivian at 1x on its 2030e Sales in 2030. With slightly higher revenues from price tailwinds, but also higher net debt we still arrive at a $6.10 target price.

Rivian’s stock has outperformed global automotive OEMs since the tariff announcement, but we see significant risks to the company’s balance sheet building. Maintain Underperform with a fresh catalyst.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note+25% RIVN $11.47 → $14.33 (Oct 9) · moving away from the target

This call✗ Not reached within 12 months: a year after the note RIVN closed at $15.99, 162% above the $6.10 target, and it moved the other way.

Firm track recordBernstein: 63% of its 8 targets at least a year old were reached within 12 months (#17 of 20 firms); on Rivian, 0 of 2. Accuracy ranking →

Bernstein on Rivian · target history
Jan 29, 2025 · $6.10 · Sell Apr 14, 2025 · $6.10 · Sell · this note
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.